Fenofibrate 145 mg Tablet – Manufacturer & Exporter in India (Fibofen-145)
Fenofibrate 145 mg Tablet Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: PPAR-alpha agonist (fibrate)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Fenofibrate 145 mg Tablet Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Fenofibrate 145 mg Tablet Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Fenofibrate 145 mg Tablet Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Fenofibrate 145 mg Tablet formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Fenofibrate Manufacturer & Supplier in India
Looking for a fenofibrate manufacturer or exporter? Trumac Healthcare supplies fenofibrate 145 mg (nanonised) tablets under the brand Fibofen-145 (10 x 10), plus fenofibrate-statin combinations, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock. Fenofibrate is prescribed by physicians and cardiologists for high triglycerides and mixed dyslipidaemia, often alongside a statin.
Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners across India. No franchise fee; minimum first order ₹25,000.
Fenofibrate range
- Fibofen-145 – fenofibrate 145 mg, 10 x 10
- Rosuron-F 20/145 – rosuvastatin 20 mg + fenofibrate 145 mg
- Rosucop-F 10/160 – rosuvastatin 10 mg + fenofibrate 160 mg
- Atorcam-F – atorvastatin 10 mg + fenofibrate 160 mg
- Full range: cardiac diabetic PCD pharma franchise
Ways to work with us
- PCD pharma franchise – fenofibrate tablets under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Who is a fenofibrate manufacturer in India for PCD and wholesale?
Trumac Healthcare supplies fenofibrate 145 mg tablets (Fibofen-145) and statin combinations made at WHO-GMP certified partner units, on monopoly PCD franchise and wholesale basis across India.
Which fenofibrate strengths and combinations are available?
Fenofibrate 145 mg; rosuvastatin + fenofibrate 20/145 and 10/160; atorvastatin + fenofibrate 10/160.
Is fenofibrate available for PCD franchise?
Yes, on a monopoly basis with our cardiac-diabetic division.
Do you export fenofibrate tablets?
Export enquiries are handled case by case; share the destination country, quantity and registration requirements on WhatsApp.
Enquiry: Share your fenofibrate requirement – franchise, wholesale or export, with quantity and location. WhatsApp +91 90416 77932.
Part of our PCD pharma franchise range, available on a monopoly basis – see the general range PCD franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Therapeutic Indications
- Severe hypertriglyceridaemia (TG > 500 mg/dL)
- Mixed dyslipidaemia
- Low HDL cholesterol with high triglycerides
- Diabetic dyslipidaemia
- Adjunct to statins in residual hypertriglyceridaemia
Mechanism of Action
Fenofibrate activates PPAR-alpha, a nuclear transcription factor regulating lipid metabolism genes. This increases lipoprotein lipase activity (clearing triglyceride-rich particles), decreases apoC-III (an LPL inhibitor) and increases apoA-I synthesis (raising HDL). Net effects: 30–50% reduction in triglycerides and modest 5–20% increase in HDL.
Dosage & Administration
- Adults: 1 tablet (145 mg) once daily, with or without food
- Take with adequate water
- Monitor lipids every 3 months
- Periodic monitoring of liver function and CK
Side Effects
- Mild GI upset
- Myalgia and muscle weakness
- Elevated liver enzymes
- Increased serum creatinine
- Cholelithiasis with prolonged use
Contraindications
- Severe hepatic impairment
- Severe renal impairment (eGFR < 30)
- Pre-existing gallbladder disease
- Hypersensitivity to fenofibrate
- Pregnancy and breastfeeding
Storage
Store below 25°C.
PCD Pharma Franchise for Fenofibrate 145 mg Tablet Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Fenofibrate 145 mg Tablet Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Fenofibrate 145 mg Tablet Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Fenofibrate 145 mg Tablet Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Fenofibrate 145 mg Tablet Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Fenofibrate 145 mg Tablet Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Fenofibrate 145 mg Tablet Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Fenofibrate 145 mg Tablet Tablet?
Available pack sizes include: 10 x 10 (Blister).
What is the MRP / trade price for Fenofibrate 145 mg Tablet Tablet?
MRPs range from ₹1250 to ₹1250 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Fenofibrate 145 mg Tablet Tablet?
